Deal valued at potentially ‘hundreds of millions of dollars, if not more,’ will see H2Pro producing Technion-developed hydrogen electrolyzers at the ‘gigawatt scale’.
Deal valued at potentially ‘hundreds of millions of dollars, if not more,’ will see H2Pro producing Technion-developed hydrogen electrolyzers at the ‘gigawatt scale’.
![[OncoHost in PR Newswire] JITC publishes OncoHost study identifying predictive proteomic signature to analyze treatment resistance in NSCLC patients](https://blog.ourcrowd.net/wp-content/themes/Extra/images/post-format-thumb-text.svg)
